PeptideNerds

Liraglutide

GLP-1 / Weight Loss FDA Approved strong evidence Track This Protocol
Alejandro Reyes

Written by Alejandro Reyes

Founder & Lead Researcher

PN

Reviewed by Peptide Nerds Editorial · Updated April 2026

Key Takeaway

Liraglutide is an older GLP-1 receptor agonist requiring daily injection. Sold as Victoza (diabetes) and Saxenda (weight loss), it has been largely superseded by weekly semaglutide but remains widely prescribed.

Quick Facts
Type GLP-1 / Weight Loss
FDA Status FDA Approved
Evidence Level Strong
Typical Dose 3.0 mg daily
Frequency Once daily subcutaneous injection
Key Goals weight-loss

How it works

Liraglutide activates the GLP-1 receptor to reduce appetite, slow gastric emptying, and improve insulin secretion. It shares the same mechanism as semaglutide but has a shorter half-life requiring daily dosing.

Benefits

  • FDA-approved for weight management
  • Well-studied safety profile
  • Available in daily injection pen format

Side effects

  • Nausea
  • Diarrhea
  • Constipation
  • Headache
  • Low blood sugar risk when combined with insulin

Dosing protocol

Typical Dose

3.0 mg daily

Frequency

Once daily subcutaneous injection

Titrate from 0.6 mg daily, increasing by 0.6 mg weekly.

Deeper on Liraglutide

Full breakdowns of every part of the Liraglutide research base.

What you will need

Basic supplies for reconstitution and subcutaneous injection.

This page contains affiliate links. Learn more

Get the Liraglutide cheat sheet

Dosing quick-reference, key studies, and side effect management — in your inbox.

Key research

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE)

New England Journal of Medicine (2015) — PubMed

8% mean body weight loss over 56 weeks vs 2.6% placebo.

FDA status

FDA Approved for: Type 2 diabetes (Victoza), weight management (Saxenda)

Where to get Liraglutide

Liraglutide requires a prescription. These telehealth platforms offer online consultations and home delivery.

This page contains affiliate links. Learn more

Get the Liraglutide cheat sheet

Dosing quick-reference, key studies, and side effect management — in your inbox.

Frequently asked questions

How does liraglutide compare to semaglutide?

Semaglutide produces roughly twice the weight loss of liraglutide (14.9% vs 8%) and only requires weekly injection versus daily. Most physicians now prefer semaglutide for weight management. Liraglutide remains an option for patients who prefer daily dosing or cannot tolerate semaglutide.

Compare Liraglutide

Related peptides

Get the Peptide Starter Kit (free)

Quick-start guide to GLP-1 peptides, dosing basics, and what to ask your doctor.

Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional medical consultation, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol.